Journal of Nutrition OpenSOurce Diets- www.ResearchDiets.com

Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow Purchase Article
Right arrow View Shopping Cart
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Liu, C.
Right arrow Articles by Wang, X.-D.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Liu, C.
Right arrow Articles by Wang, X.-D.
© 2004 The American Society for Nutritional Sciences J. Nutr. 134:426-430, February 2004


Nutrient Interactions and Toxicity

{alpha}-Tocopherol and Ascorbic Acid Decrease the Production of ß-Apo-carotenals and Increase the Formation of Retinoids from ß-Carotene in the Lung Tissues of Cigarette Smoke–Exposed Ferrets In Vitro1

Chun Liu, Robert M. Russell and Xiang-Dong Wang2

Nutrition and Cancer Biology Laboratory, Jean Mayer U.S. Department of Agriculture Human Nutrition Research Center on Aging at Tufts University, Boston, MA 02111

2To whom correspondence should be addressed. E-mail: xiang-dong.wang{at}Tufts.edu.


    ABSTRACT
 TOP
 ABSTRACT
 MATERIALS AND METHODS
 RESULTS
 DISCUSSION
 LITERATURE CITED
 
Previously, we found that exposing ferrets to cigarette smoke enhanced oxidative excentric cleavage of ß-carotene. In the present study, we examined whether {alpha}-tocopherol, ascorbic acid, or the two combined can prevent smoke-altered ß-carotene metabolism. In vitro incubation of ß-carotene (10 µmol/L) with lung postnuclear fractions from ferrets exposed to cigarette smoke was carried out in the absence or presence of {alpha}-tocopherol (50 µmol/L), ascorbic acid (10 or 50 µmol/L), or both vitamins to evaluate their effects on the production of ß-apo-carotenals and retinoids from ß-carotene. The oxidative cleavage metabolites of ß-carotene, ß-apo-carotenals (ß-apo-14', ß-apo-12', ß-apo-10', and ß-apo-8'), retinoic acid (RA), and retinal were analyzed by HPLC. We found that the smoke-enhanced production of individual ß-apo-carotenals was significantly decreased by 36–77% when {alpha}-tocopherol (50 µmol/L) and ascorbic acid (50 µmol/L) were added together to the incubation mixture. {alpha}-Tocopherol alone had a modest effect. Ascorbic acid in the presence of {alpha}-tocopherol inhibited the production of ß-apo-carotenals in a dose-dependent manner, although ascorbic acid alone had no effect. In contrast, the production of RA and retinal among smoke-exposed ferrets was substantially increased (~3-fold, P < 0.05) when both {alpha}-tocopherol and ascorbic acid were added to the incubation mixtures. However, when ascorbic acid or {alpha}-tocopherol alone was added, the production of RA among smoke-exposed ferrets increased only modestly (80%, P < 0.05) and did not differ from the RA levels in control ferrets. In conclusion, these data indicate that {alpha}-tocopherol and ascorbic acid may act synergistically in preventing the enhanced oxidative excentric cleavage of ß-carotene induced by smoking exposure, thereby facilitating the conversion of ß-carotene into RA and retinal.


KEY WORDS: • carotenoids • retinoids • {alpha}-tocopherol • ascorbic acid • cigarette smoke

It has been demonstrated that cigarette smoking substantially decreases plasma levels of ß-carotene (14) and vitamin C (47). Cigarette smoking also slightly reduces plasma levels of vitamin E (810) or {alpha}-tocopherol (1,11,12).

In our previous study, we found that exposing ferrets to cigarette smoke enhanced in vitro oxidative excentric cleavage of ß-carotene (13), which suggests that ß-carotene is unstable in the free radical–rich environment of the lungs in cigarette smokers, and that such an environment alters ß-carotene metabolism and produces oxidative excentric cleavage metabolites. Several studies including ours showed that these oxidative excentric cleavage products of ß-carotene are involved in the carcinogenic process and interfere with retinoic acid (RA)3 metabolism (1419). A possible explanation for the instability of ß-carotene in the lung is that exposure of lung cells to smoke results in increased lung cell oxidative stress, thereby decreasing other antioxidants, such as ascorbic acid and {alpha}-tocopherol, which normally have a stabilizing effect on the reduced form of ß-carotene.

Ascorbic acid, {alpha}-tocopherol, and ß-carotene are potent reducing agents that act as antioxidants in vitro and in vivo (20,21). Experimental data suggest that there are interactions among these individual antioxidants with beneficial mutual protection and regeneration. {alpha}-Tocopherol is an effective chain-breaking antioxidant, thus inhibiting lipid peroxidation (21). Ascorbic acid can regenerate {alpha}-tocopherol from the {alpha}-tocopherol radical during lipid peroxidation (21) and convert the ß-carotene radical back to its reduced form (2224). {alpha}-Tocopherol also can protect ß-carotene from autooxidation (25,26). Conversely, ß-carotene can recycle the oxidized form of {alpha}-tocopherol into its reduced form (2224,27). Therefore, using a combination of these antioxidants could be more advantageous in antioxidant protection than using a single antioxidant alone. However, it is unclear whether ascorbic acid, {alpha}-tocopherol, or both could prevent the smoke-altered ß-carotene metabolism (e.g., enhanced excentric cleavage products) in lung tissue. We thus conducted in vitro incubations of ß-carotene with lung postnuclear fractions from ferrets exposed to cigarette smoke in the presence and absence of {alpha}-tocopherol, ascorbic acid, or both vitamins.


    MATERIALS AND METHODS
 TOP
 ABSTRACT
 MATERIALS AND METHODS
 RESULTS
 DISCUSSION
 LITERATURE CITED
 
    Chemicals. All-trans-ß-carotene, all-trans-RA, all-trans-retinal, retinyl acetate echinenone, {alpha}-tocopherol, ascorbic acid, dithiothreitol (DTT), Hepes, NAD+, EDTA, potassium chloride, Tween 40, and dimethyl sulfoxide (DMSO) were purchased from Sigma Chemical. ß-Apo-8'-carotenal, apo-10'-carotenal, apo-12'-carotenal, apo-14'-carotenal were gifts from Hoffmann-La Roche. All HPLC solvents were obtained from J. T. Baker Chemical and were filtered through a 0.45-µm membrane filter before use.

    Animals, diet and study groups. The maintenance and husbandry of ferrets as well as the design of the in vivo study were described in detail elsewhere (13,28). Male ferrets were from Marshall Farms. Ferrets were fed dry ferret food (Purina Ferret Chow) and were killed by exsanguination from the heart under deep isoflurane anesthesia after the 6-mo experimental period. Lung tissues from the control group and cigarette smoke–exposed group (n = 6/group) were used in this incubation study.

    Cigarette smoke exposure. The administration of cigarette smoke exposure in ferrets was described in our previous publications (13,28). The amount of smoke exposure in the ferret is approximately equivalent to 1.5 packages of cigarettes/d in humans based upon the concentrations of urinary cotinine equivalents (13).

    Preparation of postnuclear fractions from lung tissue. We used the postnuclear fraction of lung tissue in the in vitro incubations because this fraction contains excentric cleavage activity (29). The postnuclear fractions of lung tissue were prepared according to the procedures described previously with minor modification (29,30). Briefly, ferret lung tissue was homogenized on ice in a Brinkmann Polytron homogenizer for 15 s at speed 10 with cold Hepes buffer (wt:v, 1:5), pH 7.4, containing 20 mmol/L Hepes, 1.15% KCl, 1 mmol/L EDTA, and 0.1 mmol/L DTT. The homogenate was centrifuged in a Sorval RT6000 refrigerated centrifuge (Du Pont) at 2100 x g at 4°C for 30 min. The supernatant fractions were collected and stored at -80°C. The protein concentration was determined using the bicinchroninic acid protein assay (Pierce).

    Incubation and extraction procedure. ß-Carotene was purified using a 5% water-weakened alumna column. The standard incubation mixture contained 1 mg of postnuclear protein, 10 µmol/L ß-carotene (dissolved in DMSO), 50 µmol/L {alpha}-tocopherol (dissolved in DMSO), 10 or 50 µmol/L ascorbic acid (dissolved in deionized and distilled water), 20 mmol/L Hepes buffer (pH 7.4), 2 mmol/L NAD+, 150 mmol/L KCl, 2 mmol/L DTT, and 1 mmol/L EDTA in a final volume of 1 mL. The concentration of 50 µmol/L of ascorbic acid used here was similar to the mean plasma levels in U.S. adults >= 19 y old (44 µmol/L) in the third National Health and Nutrition Examination Survey (31). The amounts of {alpha}-tocopherol and ß-carotene used here were higher than the normal plasma levels in the U.S. adults >= 19 y old (26 µmol/L for {alpha}-tocopherol, 0.4 µmol/L for ß-carotene) (31), but they were similar to the serum levels in the intervention groups [40 µmol/L (50th percentile) to 49 µmol/L (80th percentile) for {alpha}-tocopherol; 6 µmol/L (50th percentile) to 9 µmol/L (80th percentile) for ß-carotene] in the Alpha-Tocopherol, Beta Carotene Cancer Prevention Study (ATBC Study), a large clinical trial among smokers (32). The incubation mixtures were incubated under red light in glass vials at 37°C in a shaking water bath for 60 min. Two control vials that lacked either substrate or postnuclear protein were assayed. The vials were uncovered and the incubation mixtures were exposed to room air as the gas phase. After incubation, ß-apo-carotenals (ß-apo-14', ß-apo-12', ß-apo-10', and ß-apo-8'), RA, and retinal were extracted and analyzed by the method described previously with minor modification (29,30). Briefly, 100 µL of an ethanol solution of 0.5 mol/L KOH was added to the 1-mL incubation mixture to stop the reaction, followed by the addition of retinyl acetate and echinenone (internal standard) in 50 µL of ethanol. The mixture was extracted by adding 3 mL of hexane, mixing on a vortex, and then centrifuging for 10 min at 800 x g at 4°C. The hexane layer was removed. The residue was then acidified by adding 50 µL of 6 mol/L HCl. A second extraction was performed with 3 mL hexane. The two extractions were pooled, dried under N2, and resuspended in 50 µL of ethanol for injection into the HPLC system as described below.

    HPLC analysis for ß-apo-carotenals, RA, and retinal. A gradient reversed-phase HPLC was used for the analysis of ß-apo-carotenals (ß-apo-14', ß-apo-12', ß-apo-10', and ß-apo-8'), RA, and retinal as described previously with minor modification (13). Briefly, the gradient reversed-phase HPLC system consisted of a Waters 616 Pump (Waters Chromatography Division/Millipore), a Waters 600s Controller, a Waters 717 Plus autosampler, a Waters 996 photodiode array detector, a pecosphere-3 C18 0.46 x 8.3 cm reverse phase column (Perkin-Elmer) and a Waters 840-Digital 350 data station. The HPLC mobile phase was acetonitrile:tetrahydrofuran:H2O (50:20:30 by vol, 1% ammonium acetate in H2O for solvent A and 50:44:6 by vol, 1% ammonium acetate in H2O for solvent B). The gradient procedure (at a flow rate of 1 mL/min) was as follows: 100% solvent A was used for 3 min followed by a 6-min linear gradient to 40% solvent A and 60% solvent B, then a 12-min hold at 40% solvent A and 60% solvent B, and then a 7-min gradient back to 100% solvent A. In this HPLC system, RA, retinal, ß-apo-14'-carotenal, ß-apo-12'-carotenal, ß-apo-10'-carotenal, ß-apo-8'-carotenal, and ß-carotene eluted at 6.8, 8.6, 11.6, 16.3, 17.2, 19.9, and 29.5 min, respectively. Retinyl acetate (internal standard for retinoids) and echinenone (internal standard for ß-apo-carotenals) eluted at 10.1 and 25.2 min, respectively. Individual retinoids and carotenoids were identified by co-elution with standards and absorption spectrum analysis. Retinoids and carotenoids were quantified relative to the internal standard, by determining peak areas calibrated against known amounts of standards.

    Statistical analysis. Results were expressed as means ± SD and data were analyzed by one-way ANOVA followed by Tukey’s honest significant difference test. Differences were considered significant at P < 0.05.


    RESULTS
 TOP
 ABSTRACT
 MATERIALS AND METHODS
 RESULTS
 DISCUSSION
 LITERATURE CITED
 
After the incubation of ß-carotene alone with lung postnuclear fractions, the formation of ß-apo-carotenals in smoke-exposed ferrets was approximately fivefold higher for ß-apo-14' and ß-apo-8', onefold higher for ß-apo-12', and twofold higher for ß-apo-10' compared with control ferrets (Table 1). The enhanced formation of ß-apo-carotenals after smoke exposure was 68% lower for ß-apo-14', 36% lower for ß-apo-12', 60% lower for ß-apo-10', and 77% lower for ß-apo-8' when 50 µmol/L of {alpha}-tocopherol and 50 µmol/L of ascorbic acid were added to the incubation mixture together (Table 1). In the presence of {alpha}-tocopherol, ascorbic acid inhibited the formation of ß-apo-carotenals in a dose-dependent manner, although ascorbic acid alone had no effect (Fig. 1). In addition, 50 µmol/L of {alpha}-tocopherol alone significantly lowered the production of ß-apo-10' (by 38%) and ß-apo-8' (by 55%), but not ß-apo-14' and ß-apo-12'-carotenal Higher concentrations of {alpha}-tocopherol in the incubation mixture also did not affect their production (data not shown). Similarly, the combination of 50 µmol/L of {alpha}-tocopherol and 10 µmol/L of ascorbic acid significantly lowered the production of ß-apo-10' (by 47%), and ß-apo-8'-carotenal (by 70%).


View this table:
[in this window]
[in a new window]
 
TABLE 1 The production of excentric cleavage products after incubation of 10 µmol/L ß-carotene with the postnuclear fraction of lung tissue of smoke-exposed ferrets in the absence or presence of {alpha}-tocopherol and ascorbic acid or both1, 2

 


View larger version (12K):
[in this window]
[in a new window]
 
FIGURE 1 The effect of ascorbic acid concentration on the production of ß-apo-carotenals (A), retinal (B), and retinoic acid (C) from ß-carotene after incubation of 10 µmol/L of ß-carotene and 50 µmol/L of {alpha}-tocopherol with 3 mg of the lung postnuclear proteins of smoke-exposed ferrets for 60 min. Values are means ± SD, n = 6.

 
Smoke exposure significantly lowered the production of RA from ß-carotene, but not retinal compared with controls not exposed to smoke (Table 2). However, the production of RA in the lung postnuclear fractions of smoke-exposed ferrets was significantly higher (by approximately twofold) when 50 µmol/L of {alpha}-tocopherol combined with either 10 or 50 µmol/L of ascorbic acid was added to the incubation mixtures (Table 2). When 50 µmol/L of {alpha}-tocopherol alone or ascorbic acid alone at either 10 or 50 µmol/L concentrations was added to the incubation mixtures, the production of RA in the lung postnuclear fractions of smoke-exposed ferrets was also significantly higher (~80%) compared with that in the lung postnuclear fractions of smoke-exposed ferrets without additions of either {alpha}-tocopherol or ascorbic acid. However, the increased production of RA by {alpha}-tocopherol or ascorbic acid alone only reached levels that were similar to that of control ferrets. In addition, {alpha}-tocopherol alone or the combination of {alpha}-tocopherol and ascorbic acid at either 10 or 50 µmol/L also significantly increased the production of retinal compared with control ferrets (by 60%, 2.2-fold, and 2.3-fold, respectively) (Table 2).


View this table:
[in this window]
[in a new window]
 
TABLE 2 The production of retinoids after incubation of 10 µmol/L ß-carotene with the postnuclear fraction of lung tissue of smoke-exposed ferrets in the absence or presence of {alpha}-tocopherol and ascorbic acid or both1, 2

 

    DISCUSSION
 TOP
 ABSTRACT
 MATERIALS AND METHODS
 RESULTS
 DISCUSSION
 LITERATURE CITED
 
In the present incubation study, we demonstrated that the smoke-enhanced production of ß-apo-carotenals, excentric cleavage oxidative metabolites of ß-carotene, was decreased by the combination of {alpha}-tocopherol and ascorbic acid. In contrast, the production of RA among smoke-exposed ferrets was substantially elevated by the combination of {alpha}-tocopherol and ascorbic acid. These findings may have potential implications in cancer prevention because excentric cleavage oxidative metabolites of ß-carotene could be related to carcinogenesis. ß-Carotene metabolites were shown to facilitate the binding of benzo[a]pyrene metabolites to DNA (14). Furthermore, Perocco et al. (15) found that the induction of BALB/c 3T3 cell transformation by benzo[a] pyrene was markedly enhanced by the addition of ß-carotene, although from their study it is uncertain whether the enhancement of cell-transforming activity of ß-carotene was due to ß-carotene itself or its metabolites. Excentric cleavage oxidative metabolites of ß-carotene may also be associated with carcinogenesis through their induction of cytochrome P450 enzymes, which can convert protocarcinogens into activated carcinogens, facilitate lipid peroxidation, or enhance RA catabolism, thereby diminishing retinoid signaling (18). For example, ß-apo-8'-carotenal was shown to be a strong inducer of cytochrome P450 enzymes (17). Several studies have shown that ß-apo-carotenals inhibit mitochondria respiration and elevate the accumulation of malondialdehyde in vitro (33,34). Recently, we observed that the formation of polar metabolites of RA (including 18-hydroxy RA and 4-oxo-RA) increased after incubation of RA with lung tissue from ferrets that were exposed to cigarette smoke or supplemented with high doses of ß-carotene (19). RA plays an important role in modulating cell proliferation and differentiation of lung epithelial cells, and suppresses carcinogenesis in certain epithelial tissues (35).

To the best of our knowledge, there is no previous study on the effects of the combination of {alpha}-tocopherol and ascorbic acid on the production of excentric or central cleavage oxidative metabolites of ß-carotene associated with smoke exposure. We demonstrated that the combination of {alpha}-tocopherol and ascorbic acid had a stronger effect on the inhibition of the smoke-enhanced formation of excentric cleavage oxidative metabolites of ß-carotene, and on the restoration of the smoke-reduced production of central cleavage metabolites of ß-carotene than did either {alpha}-tocopherol or ascorbic acid alone. Our findings provide potential explanations for the observed synergistic protective effects of {alpha}-tocopherol, ascorbic acid, and ß-carotene in combination against oxidative damage in an in vitro cell system (23,26,36,37) and in humans exposed to environmental tobacco smoke (3841).

The effect of {alpha}-tocopherol alone on ß-carotene metabolism without smoke exposure was evaluated in two previous studies. In an in vivo experiment of ferrets perfused with ß-carotene and various concentrations of {alpha}-tocopherol, the production of ß-apo-12' carotenal in intestinal mucosa was gradually decreased with increasing concentrations of {alpha}-tocopherol, albeit this change was not significant. However, the production of retinal, a central cleavage product of ß-carotene, was significantly increased (42). In the present study, we observed that {alpha}-tocopherol alone decreased the production of other the smoke-induced ß-apo-carotenals, including ß-apo-14', ß-apo-12', ß-apo-10' and ß-apo-8'. The reduction was significant for the latter two metabolites. In an in vitro incubation experiment using intestinal mucosa from apparently healthy rats, with the addition of {alpha}-tocopherol, ß-carotene’s excentric cleavage products were almost completely blocked and ß-carotene was converted exclusively into the central cleavage product of retinal (43). In the present study, {alpha}-tocopherol alone did not completely block the formation of excentric cleavage metabolites of ß-carotene, which may be explained by the fact that the excentric cleavage metabolites of ß-carotene were substantially induced by smoke exposure in the present study (Table 1). Several other factors such as different species and organs of animals may also contribute to the discrepancy in the magnitudes of the inhibitory effects of {alpha}-tocopherol on the production of ß-apo-carotenals from ß-carotene in the various studies.

Ascorbic acid, which can facilitate both {alpha}-tocopherol recycling and ß-carotene stability (23), is an important part of antioxidant defense under conditions of smoke exposure. Ascorbic acid itself was shown to protect lipids against peroxidative damage in human plasma by scavenging oxygen-derived free radicals (20). Epidemiologic studies have demonstrated consistently that diets high in fruit and vegetables, and hence high in ascorbic acid, are associated with a lower risk for cancers of the lung, oral cavity, esophagus, and stomach (44). Smoking, however, substantially lowers circulating ascorbic acid levels (47). In the ATBC Study, a randomized clinical trial among 29,133 male smokers, 50 mg/d {alpha}-tocopherol supplementation combined with 20 mg/d ß-carotene for 5–8 y did not protect against smoke-related lung cancer (32). Although plasma ascorbic acid levels were not reported in the ATBC study, lower levels of plasma ascorbic acid would be expected among the smoking participants in that study than in a nonsmoking population. This may have resulted in a loss of protection usually conferred by ascorbic acid on {alpha}-tocopherol and ß-carotene. Although, in the present study, ascorbic acid alone had no effect on the inhibition of the formation of ß-apo-carotenals, it appeared to interact with {alpha}-tocopherol to protect against the formation of excentric cleavage products from ß-carotene because the inhibitory effects of the combination of {alpha}-tocopherol and ascorbic acid on excentric cleavage production of ß-carotene were significantly greater than with {alpha}-tocopherol alone.

Data from the present study suggest that adding {alpha}-tocopherol and ascorbic acid when using high doses of ß-carotene may prevent excessive formation of excentric cleavage products of ß-carotene and the subsequent cascade of events that may result from them (i.e., bioactivating carcinogens, destroying RA via induction of cytochrome P450 enzymes, and facilitating the binding of benzo[a]pyrene metabolites to DNA). Using a combination of antioxidant nutrients that can provide mutual protection and regeneration might prove to be an effective chemopreventive strategy against lung cancer in smokers.


    FOOTNOTES
 
1 Supported by National Institutes of Health grant CA49195, and U.S. Department of Agriculture, under agreement no. 1950–51000-056–01A. Any opinions, findings, conclusion, or recommendations expressed in this publication are those of the author(s) and do not necessarily reflect the views of the U.S. Department of Agriculture. Back

3 Abbreviations used: ATBC Study, Alpha-Tocopherol, Beta Carotene Cancer Prevention Study; DMSO, dimethyl sulfoxide; DTT, dithiothreitol; RA, retinoic acid. Back

Manuscript received 22 September 2003. Initial review completed 16 October 2003. Revision accepted 11 November 2003.


    LITERATURE CITED
 TOP
 ABSTRACT
 MATERIALS AND METHODS
 RESULTS
 DISCUSSION
 LITERATURE CITED
 

1. Alberg, A. J., Chen, J. C., Zhao, H., Hoffman, S. C., Comstock, G. W. & Helzlsouer, K. J. (2000) Household exposure to passive cigarette smoking and serum micronutrient concentrations. Am. J. Clin. Nutr. 72:1576-1582.[Abstract/Free Full Text]

2. Fukao, A., Tsubono, Y., Kawamura, M., Ido, T., Akazawa, N., Tsuji, I., Komatsu, S., Minami, Y. & Hisamichi, S. (1996) The independent association of smoking and drinking with serum beta-carotene levels among males in Miyagi, Japan. Int. J. Epidemiol. 25:300-306.[Abstract/Free Full Text]

3. Shibata, A., Sasaki, R., Ito, Y., Hamajima, N., Suzuki, S., Ohtani, M. & Aoki, K. (1989) Serum concentration of beta-carotene and intake frequency of green-yellow vegetables among healthy inhabitants of Japan. Int. J. Cancer 44:48-52.[Medline]

4. Wei, W., Kim, Y. & Boudreau, N. (2001) Association of smoking with serum and dietary levels of antioxidants in adults: NHANES III, 1988–1994. Am. J. Public Health 91:258-264.[Abstract]

5. Pelletier, O. (1975) Vitamin C and cigarette smokers. Ann. N.Y. Acad. Sci. 258:156-168.[Medline]

6. Schectman, G., Byrd, J. C. & Gruchow, H. W. (1989) The influence of smoking on vitamin C status in adults. Am. J. Public Health 79:158-162.[Abstract/Free Full Text]

7. Ross, M. A., Crosley, L. K., Brown, K. M., Duthie, S. J., Collins, A. C., Arthur, J. R. & Duthie, G. G. (1995) Plasma concentrations of carotenoids and antioxidant vitamins in Scottish males: influences of smoking. Eur. J. Clin. Nutr. 49:861-865.[Medline]

8. Bolton-Smith, C., Casey, C. E., Gey, K. F., Smith, W. C. & Tunstall-Pedoe, H. (1991) Antioxidant vitamin intakes assessed using a food-frequency questionnaire: correlation with biochemical status in smokers and non-smokers. Br. J. Nutr. 65:337-346.[Medline]

9. Tappia, P. S., Troughton, K. L., Langley-Evans, S. C. & Grimble, R. F. (1995) Cigarette smoking influences cytokine production and antioxidant defences. Clin. Sci. (Lond.) 88:485-489.[Medline]

10. Theron, A. J., Richards, G. A., Myer, M. S., van Antwerpen, V. L., Sluis-Cremer, G. K., Wolmarans, L., van der Merwe, C. A. & Anderson, R. (1994) Investigation of the relative contributions of cigarette smoking and mineral dust exposure to activation of circulating phagocytes, alterations in plasma concentrations of vitamin C, vitamin E, and beta carotene, and pulmonary dysfunction in South African gold miners. Occup. Environ. Med. 51:564-567.[Abstract]

11. Hebert, J. R., Hurley, T. G., Hsieh, J., Rogers, E., Stoddard, A. M., Sorensen, G. & Nicolosi, R. J. (1994) Determinants of plasma vitamins and lipids: the Working Well Study. Am. J. Epidemiol. 140:132-147.[Abstract/Free Full Text]

12. Stryker, W. S., Kaplan, L. A., Stein, E. A., Stampfer, M. J., Sober, A. & Willett, W. C. (1988) The relation of diet, cigarette smoking, and alcohol consumption to plasma beta-carotene and alpha-tocopherol levels. Am. J. Epidemiol. 127:283-296.[Abstract/Free Full Text]

13. Wang, X. D., Liu, C., Bronson, R. T., Smith, D. E., Krinsky, N. I. & Russell, M. (1999) Retinoid signaling and activator protein-1 expression in ferrets given beta-carotene supplements and exposed to tobacco smoke. J. Natl. Cancer Inst. 91:60-66.[Abstract/Free Full Text]

14. Salgo, M. G., Cueto, R., Winston, G. W. & Pryor, W. A. (1999) Beta carotene and its oxidation products have different effects on microsome mediated binding of benzo[a]pyrene to DNA. Free Radic. Biol. Med. 26:162-173.[Medline]

15. Perocco, P., Paolini, M., Mazzullo, M., Biagi, G. L. & Cantelli-Forti, G. (1999) Beta-carotene as enhancer of cell transforming activity of powerful carcinogens and cigarette-smoke condensate on BALB/c 3T3 cells in vitro. Mutat. Res. 440:83-90.[Medline]

16. Lowe, G. M., Booth, L. A., Young, A. J. & Bilton, R. F. (1999) Lycopene and beta-carotene protect against oxidative damage in HT29 cells at low concentrations but rapidly lose this capacity at higher doses. Free Radic. Res. 30:141-151.[Medline]

17. Gradelet, S., Leclerc, J., Siess, M. H. & Astorg, P. O. (1996) ß-Apo-8'-carotenal, but not ß-carotene, is a strong inducer of liver cytochromes P4501A1 and 1A2 in rat. Xenobiotica 26:909-919.[Medline]

18. Wang, X. D. & Russell, R. M. (1999) Procarcinogenic and anticarcinogenic effects of beta-carotene. Nutr. Rev. 57:263-272.[Medline]

19. Liu, C., Russell, R. M. & Wang, X. D. (2003) Exposing ferrets to cigarette smoke and a pharmacological dose of ß-carotene supplementation enhance in vitro retinoic acid catabolism in lungs via induction of cytochrome P450 enzymes. J. Nutr. 133:173-179.[Abstract/Free Full Text]

20. Frei, B., Forte, T. M., Ames, B. N. & Cross, C. E. (1991) Gas phase oxidants of cigarette smoke induce lipid peroxidation and changes in lipoprotein properties in human blood plasma. Protective effects of ascorbic acid. Biochem. J. 277:133-138.

21. Frei, B. (1994) Reactive oxygen species and antioxidant vitamins: mechanisms of action. Am. J. Med. 97:5S-13S discussion, 22S–28S.[Medline]

22. Böhm, F. (1997) Carotenoids enhance vitamin E antioxidant efficiency. J. Am. Chem. Soc. 119:621-622.

23. Böhm, F., Edge, R., McGarvey, D. J. & Truscott, T. G. (1998) Beta-carotene with vitamins E and C offers synergistic cell protection against NOx. FEBS Lett. 436:387-389.[Medline]

24. Black, H. S. (1998) Radical interception by carotenoids and effects on UV carcinogenesis. Nutr. Cancer 31:212-217.[Medline]

25. Handelman, G. J., van Kuijk, F. J., Chatterjee, A. & Krinsky, N. I. (1991) Characterization of products formed during the autoxidation of beta-carotene. Free Radic. Biol. Med. 10:427-437.[Medline]

26. Palozza, P. & Krinsky, N. I. (1992) ß-Carotene and {alpha}-tocopherol are synergistic antioxidants. Arch. Biochem. Biophys. 297:184-187.[Medline]

27. Edge, R. (1998) Relative one-electron reduction potentials of carotenoid radical cations and the interactions of carotenoids with the vitamin E radical cation. J. Am. Chem. Soc. 120:4087-4090.

28. Liu, C., Wang, X. D., Bronson, R. T., Smith, D. E., Krinsky, N. I. & Russell, R. M. (2000) Effects of physiological versus pharmacological beta-carotene supplementation on cell proliferation and histopathological changes in the lungs of cigarette smoke-exposed ferrets. Carcinogenesis 21:2245-2253.[Abstract/Free Full Text]

29. Wang, X. D., Tang, G. W., Fox, J. G., Krinsky, N. I. & Russell, R. M. (1991) Enzymatic conversion of beta-carotene into beta-apo-carotenals and retinoids by human, monkey, ferret, and rat tissues. Arch. Biochem. Biophys. 285:8-16.[Medline]

30. Wang, X. D. & Krinsky, N. I. (1997) Identification and quantification of retinoic acid and other metabolites from beta-carotene excentric cleavage in human intestine in vitro and ferret intestine in vivo. Methods Enzymol. 282:117-130.[Medline]

31. Food and Nutrition Board, Institute of Medicine (2000) Dietary Reference Intakes for Vitamin C, Vitamin E, Selenium, and Carotenoids. A Report of the Panel on Dietary Antioxidants and Related Compounds, Subcommittees on Upper Reference Levels of Nutrients and Interpretation and Uses of Dietary Reference Intakes, and the Standing Committee on the Scientific Evaluation of Dietary Reference Intakes 2000 National Academy Press Washington, DC.

32. The Alpha-Tocopherol, Beta Carotene Cancer Prevention Study Group (1994) The effect of vitamin E and beta-carotene on the incidence of lung cancer and other cancers in male smokers. N. Engl. J. Med. 330:1029-1035.[Abstract/Free Full Text]

33. Siems, W., Sommerburg, O., Schild, L., Augustin, W., Langhans, C. D. & Wiswedel, I. (2002) Beta-carotene cleavage products induce oxidative stress in vitro by impairing mitochondrial respiration. FASEB J. 16:1289-1291.[Abstract/Free Full Text]

34. Siems, W. G., Sommerburg, O., Hurst, J. S. & van Kuijk, F. J. (2000) Carotenoid oxidative degradation products inhibit Na+-K+-ATPase. Free Radic. Res. 33:427-435.[Medline]

35. Lippman, S. M. & Lotan, R. (2000) Advances in the development of retinoids as chemopreventive agents. J. Nutr. 130:479S-482S.

36. Böhm, F., Edge, R., Foley, S., Lange, L. & Truscott, T. G. (2001) Antioxidant inhibition of porphyrin-induced cellular phototoxicity. J. Photochem. Photobiol. B 65:177-183.[Medline]

37. Offord, E. A., Gautier, J. C., Avanti, O., Scaletta, C., Runge, F., Kramer, K. & Applegate, L. A. (2002) Photoprotective potential of lycopene, beta-carotene, vitamin E, vitamin C and carnosic acid in UVA-irradiated human skin fibroblasts. Free Radic. Biol. Med. 32:1293-1303.[Medline]

38. Yong, L. C., Brown, C. C., Schatzkin, A., Dresser, C. M., Slesinski, M. J., Cox, C. S. & Taylor, P. R. (1997) Intake of vitamins E, C, and A and risk of lung cancer. The NHANES I epidemiologic followup study. First National Health and Nutrition Examination Survey. Am. J. Epidemiol. 146:231-243.[Abstract/Free Full Text]

39. Howard, D. J., Ota, R. B., Briggs, L. A., Hampton, M. & Pritsos, C. A. (1998) Oxidative stress induced by environmental tobacco smoke in the workplace is mitigated by antioxidant supplementation. Cancer Epidemiol. Biomark. Prev. 7:981-988.[Abstract]

40. Chao, J. C., Huang, C. H., Wu, S. J., Yang, S. C., Chang, N. C., Shieh, M. J. & Lo, P. N. (2002) Effects of beta-carotene, vitamin C and E on antioxidant status in hyperlipidemic smokers. J. Nutr. Biochem. 13:427-434.[Medline]

41. Duthie, S. J., Ma, A., Ross, M. A. & Collins, A. R. (1996) Antioxidant supplementation decreases oxidative DNA damage in human lymphocytes. Cancer Res. 56:1291-1295.[Abstract/Free Full Text]

42. Wang, X. D., Marini, R. P., Hebuterne, X., Fox, J. G., Krinsky, N. I. & Russell, R. M. (1995) Vitamin E enhances the lymphatic transport of beta-carotene and its conversion to vitamin A in the ferret. Gastroenterology 108:719-726.[Medline]

43. Yeum, K. J., dos Anjos Ferreira, A. L., Smith, D., Krinsky, N. I. & Russell, R. M. (2000) The effect of alpha-tocopherol on the oxidative cleavage of beta-carotene. Free Radic. Biol. Med. 29:105-114.[Medline]

44. Byers, T. & Guerrero, N. (1995) Epidemiologic evidence for vitamin C and vitamin E in cancer prevention. Am. J. Clin. Nutr. 62:1385S-1392S.[Abstract/Free Full Text]




This article has been cited by other articles:


Home page
CarcinogenesisHome page
Y. Kim, N. Chongviriyaphan, C. Liu, R. M. Russell, and X.-D. Wang
Combined antioxidant ({beta}-carotene, {alpha}-tocopherol and ascorbic acid) supplementation increases the levels of lung retinoic acid and inhibits the activation of mitogen-activated protein kinase in the ferret lung cancer model
Carcinogenesis, July 1, 2006; 27(7): 1410 - 1419.
[Abstract] [Full Text] [PDF]


Home page
J. Nutr.Home page
J. Limpens, F. H. Schroder, C. M. A. de Ridder, C. A. Bolder, M. F. Wildhagen, U. C. Obermuller-Jevic, K. Kramer, and W. M. van Weerden
Combined Lycopene and Vitamin E Treatment Suppresses the Growth of PC-346C Human Prostate Cancer Cells in Nude Mice
J. Nutr., May 1, 2006; 136(5): 1287 - 1293.
[Abstract] [Full Text] [PDF]


Home page
CarcinogenesisHome page
S. S. Hecht
Carcinogenicity studies of inhaled cigarette smoke in laboratory animals: old and new
Carcinogenesis, September 1, 2005; 26(9): 1488 - 1492.
[Abstract] [Full Text] [PDF]


This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow Purchase Article
Right arrow View Shopping Cart
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Liu, C.
Right arrow Articles by Wang, X.-D.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Liu, C.
Right arrow Articles by Wang, X.-D.


Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]